Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.
Audia S, Samson M, Mahévas M, Ferrand C, Trad M, Ciudad M, Gautheron A, Seaphanh F, Leguy V, Berthier S, Salles B, Martin L, Lorcerie B, Ortega-Deballon P, Facy O, Caillot D, Soudry-Faure A, Michel M, Godeau B, Larmonier N, Saas P, Janikashvili N, Bonnotte B.
Audia S, et al. Among authors: mahevas m.
Blood. 2013 Oct 3;122(14):2477-86. doi: 10.1182/blood-2013-03-491415. Epub 2013 Aug 20.
Blood. 2013.
PMID: 23963041
Free article.